News
-
Artificial intelligence as the co-pilot for drug discovery23 May 2023There are more molecules that could conceivably be candidate drugs than there are stars in the universe. How can we ever efficiently identify those mo...
-
Horizon Europe grant for research into personalised treatment for high blood pressure18 April 2023Professor Thomas Hankemeier and his international research team HYPERMARKER have received a 10m-euro grant from Horizon Europe and UK Research and Inn...
-
LUMC researchers: matching medication to DNA leads to 30% fewer side effects03 February 2023According to an international group of researchers led by Leiden University Medical Center (LUMC), patients experience 30% fewer serious side effects ...
-
Cells with stress: predicting drug-induced liver and kidney damage26 January 2023How can we prevent drug-induced liver and kidney damage? PhD candidates Marije Niemeijer and Lukas Wijaya investigated what happens in the cells durin...
-
From discovery to business: 'In the lab, we often don't realise that we are working to help an immense number of patients'06 October 2022'It gave our team a big boost to hear that our work was valuable,' says medical chemist Elmer Maurits about the moment they won the Venture Challenge....
-
Developing drugs with artificial intelligence07 February 2022Developing new drugs is a difficult process. With the aid of artificial intelligence, Pharmaceutical scientist Xuhan Liu has developed methods that ca...
-
Drugging the undruggable: NWO Open Competition grant for Alireza Mashaghi04 January 2022Finding structure in disordered proteins and developing drugs for undruggable diseases: it might sound like mission impossible, but pharmacologist Ali...
-
Adam Cohen receives Dr. Saal van Zwanenberg Honorary Prize12 November 2021Professor of Clinical Pharmacology Adam Cohen from Leiden University received the prestigious Dr. Saal van Zwanenberg Honorary Prize on 12 November. T...
-
Pharma company Janssen expands premises on Leiden Bio Science Park03 November 2021Pharma company Janssen has begun construction on a new office and lab building at the Leiden Bio Science Park. The first pile of the 13,500 square met...
-
Erik Danen part of NWO Perspectief grant for organ-on-chip10 March 2021A consortium of research groups, including that of LACDR professor Erik Danen, will use an NWO Perspective grant of nearly five million euros to build...
-
Medical Delta AI for Computational Life Sciences16 February 2021The fact that scientists are increasingly better able to access molecular cell and tissue data also brings with it a new challenge: how can scientists...
-
Laura Heitman appointed as Professor of Molecular Pharmacology26 November 2020As of 1 November, Laura Heitman has been appointed full Professor of Molecular Pharmacology at the Leiden Academic Centre for Drug Research (LACDR). H...
-
Leiden University and LUMC strengthen ties with Janssen pharmaceutical company17 September 2020Leiden University, the LUMC and Janssen have signed a partnership agreement stating that they will collaborate in different areas, including infectiou...
-
Paradigm-shifting theory highlights the importance of substrate flexibility in enzymatic reactions30 July 2020Leiden chemists have proposed a new model for enzymatic reactions, in which the flexibility of the substrate is much more important than previously th...
-
Phenomix Field Lab offers promising healthcare solutions13 July 2020In the Phenomix Medical Delta Field Lab, which was officially opened on Thursday 9 July, scientists, healthcare institutions and businesses work toget...